drugset / Trial / NCT01254552

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

NCT01254552

Phase 4 Completed 351 enrolled Guerbet
NaSingle-groupOpen-labelDiagnostic

Summary

The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).

Timeline

Start
2010-08
Primary completion
2011-09
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoterate meglumine Diagnostic / imaging agent 0.1 unknown
Subject Iobitridol Diagnostic / imaging agent 180 ml